− Reduces Relapses, Disability Progression and Brain Lesions with a Favorable Safety Profile − Only Pegylated Interferon in MS, Dosed Once Every Two Weeks − Complements …
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis
– Reduces Relapses, Disability Progression, and MRI Brain Lesions, with a Favorable Safety Profile Consistent with the Established Interferon Class – Initial Country Launches …